Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing the use of genome-wide association studies for drug repurposing
William R. Reay, Murray J. Cairns
Nature Reviews Genetics (2021) Vol. 22, Iss. 10, pp. 658-671
Closed Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Plasma proteomic associations with genetics and health in the UK Biobank
Benjamin B. Sun, Joshua Chiou, Matthew Traylor, et al.
Nature (2023) Vol. 622, Iss. 7982, pp. 329-338
Open Access | Times Cited: 462
The immunology of multiple sclerosis
Kathrine E. Attfield, Lise T. Jensen, Max Kaufmann, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 734-750
Closed Access | Times Cited: 210
Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Jianfeng Lin, Jiawei Zhou, Yan Xu
Brain (2023) Vol. 146, Iss. 8, pp. 3364-3372
Open Access | Times Cited: 152
Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants
Benjamin B. Sun, Joshua Chiou, Matthew Traylor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 103
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture
Remi Stevelink, Ciarán Campbell, Siwei Chen, et al.
Nature Genetics (2023) Vol. 55, Iss. 9, pp. 1471-1482
Open Access | Times Cited: 81
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Jiansong Fang, Pengyue Zhang, Quan Wang, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 78
Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease
Ziang Li, Bin Zhang, Qing‐Rong Liu, et al.
EBioMedicine (2023) Vol. 90, pp. 104543-104543
Open Access | Times Cited: 78
Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, et al.
Nature (2024) Vol. 629, Iss. 8012, pp. 624-629
Open Access | Times Cited: 76
Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders
William R. Reay, Dylan J. Kiltschewskij, Michael P. Geaghan, et al.
Science Advances (2022) Vol. 8, Iss. 14
Open Access | Times Cited: 70
From genetic associations to genes: methods, applications, and challenges
Ting Qi, Liyang Song, Yazhou Guo, et al.
Trends in Genetics (2024) Vol. 40, Iss. 8, pp. 642-667
Open Access | Times Cited: 15
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
Liwan Fu, Qin Liu, Hong Cheng, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 2
Gene-level analysis reveals the genetic aetiology and therapeutic targets of schizophrenia
Xinglun Dang, Zhaowei Teng, Yongfeng Yang, et al.
Nature Human Behaviour (2025)
Closed Access | Times Cited: 1
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry
Dhoha Dhieb, Kholoud Bastaki
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1082-1082
Open Access | Times Cited: 1
Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders
Jiewei Liu, Yuqi Cheng, Ming Li, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 2, pp. 270-280
Open Access | Times Cited: 44
Wrestling with Social and Behavioral Genomics: Risks, Potential Benefits, and Ethical Responsibility
Michelle N. Meyer, Paul S. Appelbaum, Daniel J. Benjamin, et al.
The Hastings Center Report (2023) Vol. 53, Iss. S1
Open Access | Times Cited: 38
Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
sc2GWAS: a comprehensive platform linking single cell and GWAS traits of human
Mingxue Yin, Chenchen Feng, Zhengmin Yu, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1151-D1161
Open Access | Times Cited: 11
Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses
Wei Zhang, Leilei Ma, Qianyi Zhou, et al.
Diabetes (2024) Vol. 73, Iss. 4, pp. 618-627
Open Access | Times Cited: 10
Genetic influences on circulating retinol and its relationship to human health
William R. Reay, Dylan J. Kiltschewskij, Maria A. Di Biase, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
Manal M. Hassan, Donghui Li, Younghun Han, et al.
Hepatology (2024) Vol. 80, Iss. 1, pp. 87-101
Open Access | Times Cited: 8
Genomic Risk Factors for Cervical Cancer
Dhanya Ramachandran, Thilo Dörk
Cancers (2021) Vol. 13, Iss. 20, pp. 5137-5137
Open Access | Times Cited: 51
A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis
Shinichi Namba, Takahiro Konuma, Kuan-Han Wu, et al.
Cell Genomics (2022) Vol. 2, Iss. 10, pp. 100190-100190
Open Access | Times Cited: 33
A flexible modeling and inference framework for estimating variant effect sizes from GWAS summary statistics
Jeffrey P. Spence, Nasa Sinnott-Armstrong, Themistocles L. Assimes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 30
Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
Chengran Yang, Anne M. Fagan, Richard J. Perrin, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Precision medicine for cardiometabolic disease: a framework for clinical translation
Paul W. Franks, William T. Cefalu, John Dennis, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 11, pp. 822-835
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top